Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
Clinical trial NCT05782907 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05782907
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2028-08-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.